|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis5 A/ P( X2 f4 I/ B: R' i' K: u
was to close its brain research facility in Basel, Switzerland,
; _5 t7 P7 f8 A8 hthe story noted that this move closely followed similar cuts% i$ i, r% ^5 w2 O
by rival pharmaceutical firms. As a report from the European College- s' W6 P9 o3 v9 C, e {) @. F
of Neuropsychopharmacology
) b* L: P2 e& p* Chad warned a few months earlier, the
/ B. R5 n2 \; X. L! Habandonment of research into new psychiatric drugs by AstraZeneca, i2 Q* u4 D, I+ C
GlaxoSmithKline
% N* d& ?" k: `, |and others meant that “withdrawal of research1 O$ N5 p3 U' R8 n' i& J
resources is a withdrawal of hope for patients and their families”.2 @/ V9 o0 k' F# |1 \# l! ]$ W6 P& t
4 }7 w2 s9 P" v( l* }( S
+ v0 z" E1 ]7 m: d
回复有免费下载链接0 R( s/ [2 P6 q8 k' `% ^/ j
1 u9 h) z6 u" i6 a+ u7 z( J
|
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
